Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New strategies to improve clinical outcomes for diabetic kidney disease.
Forst T, Mathieu C, Giorgino F, Wheeler DC, Papanas N, Schmieder RE, Halabi A, Schnell O, Streckbein M, Tuttle KR. Forst T, et al. Among authors: giorgino f. BMC Med. 2022 Oct 10;20(1):337. doi: 10.1186/s12916-022-02539-2. BMC Med. 2022. PMID: 36210442 Free PMC article. Review.
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study.
Fioretto P, Del Prato S, Buse JB, Goldenberg R, Giorgino F, Reyner D, Langkilde AM, Sjöström CD, Sartipy P; DERIVE Study Investigators. Fioretto P, et al. Among authors: giorgino f. Diabetes Obes Metab. 2018 Nov;20(11):2532-2540. doi: 10.1111/dom.13413. Epub 2018 Jul 10. Diabetes Obes Metab. 2018. PMID: 29888547 Free PMC article. Clinical Trial.
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Schnell O, Cos X, Cosentino F, Forst T, Giorgino F, Heersprink HJL, Kosiborod M, Wanner C, Standl E. Schnell O, et al. Among authors: giorgino f. Cardiovasc Diabetol. 2021 Mar 31;20(1):75. doi: 10.1186/s12933-021-01254-1. Cardiovasc Diabetol. 2021. PMID: 33789663 Free PMC article.
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis.
Cignarelli A, Genchi VA, Le Grazie G, Caruso I, Marrano N, Biondi G, D'Oria R, Sorice GP, Natalicchio A, Perrini S, Laviola L, Giorgino F. Cignarelli A, et al. Among authors: giorgino f. Front Endocrinol (Lausanne). 2022 Feb 21;13:846903. doi: 10.3389/fendo.2022.846903. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35265043 Free PMC article. Review.
365 results